#RXRX Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration

https://www.stocktitan.net/news/RXRX/recursion-announces-sanofi-options-potential-first-in-class-t18s9v21zzk2.html?utm_source=stocktitan-bluesky&utm_medium=social

#RXRX Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock

https://www.stocktitan.net/news/RXRX/recursion-announces-pricing-of-200-million-underwritten-offering-of-53x9xkhqq9dz.html?utm_source=stocktitan-bluesky&utm_medium=social

#RXRX Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone

https://www.stocktitan.net/news/RXRX/recursion-announces-200-million-oversubscribed-follow-on-offering-8pxp4hvk1jof.html?utm_source=stocktitan-bluesky&utm_medium=social

🔴 $RXRX — HERSHBERG ROBERT, Director
SOLD: 25,000 shares @ $5.00
Total: $125K
Filed Oct 5, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/RXRX

#InsiderTrading #RXRX #StockMarket

🔴 $RXRX — Borgeson Blake, Director
SOLD: 50,000 shares @ $4.84
Total: $242K
Filed Oct 5, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/RXRX

#InsiderTrading #RXRX #StockMarket

📢 Stocks Trending NOW: #CEG #NVAX #AMD #RXRX #BEAT #WBD #PSKY #MRNA #OPCH #SHOP

There are a lot of ways to get exposure across that stack, from biological data and diagnostics through #TEM, to synthetic DNA through #TWST, AI drug discovery through #RXRX, and scaled drug developers like #LLY that have the capital and infrastructure to commercialize what actually works.